Utah Medical Products Inc financial data

Symbol
UTMD on Nasdaq
Location
7043 S 300 West, Midvale, UT
State of incorporation
UT
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.45K % +22.7%
Quick Ratio 218 % +11.4%
Debt-to-equity 4.92 % -27%
Operating Margin 33.2 % -0.51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.28M shares -8.56%
Common Stock, Shares, Outstanding 3.34M shares -8.13%
Entity Public Float 216M USD -31.1%
Common Stock, Value, Issued 33K USD -8.33%
Weighted Average Number of Shares Outstanding, Basic 3.5M shares -3.47%
Weighted Average Number of Shares Outstanding, Diluted 3.5M shares -3.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 40.9M USD -18.6%
Research and Development Expense 813K USD +45.2%
Operating Income (Loss) 13.6M USD -19%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 16.8M USD -16.4%
Income Tax Expense (Benefit) 2.93M USD -15.2%
Earnings Per Share, Basic 3.96 USD/shares -13.5%
Earnings Per Share, Diluted 3.96 USD/shares -13.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83M USD -10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 4.09M USD +20.7%
Inventory, Net 8.81M USD -8.04%
Other Assets, Current 448K USD +4.67%
Assets, Current 96.3M USD -9.35%
Property, Plant and Equipment, Net 9.76M USD -7.47%
Operating Lease, Right-of-Use Asset 338K USD -1.17%
Intangible Assets, Net (Excluding Goodwill) 2.87M USD -42.1%
Goodwill 13.6M USD -0.82%
Assets 123M USD -9.54%
Accounts Payable, Current 696K USD -9.49%
Employee-related Liabilities, Current 1.15M USD -11.3%
Accrued Liabilities, Current 3.06M USD -22.3%
Liabilities, Current 3.76M USD -20.2%
Long-term Debt and Lease Obligation 282K USD -4.41%
Deferred Income Tax Liabilities, Net 469K USD +45.7%
Operating Lease, Liability, Noncurrent 282K USD -4.41%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 5.11M USD -28.5%
Retained Earnings (Accumulated Deficit) 129M USD -6.53%
Stockholders' Equity Attributable to Parent 117M USD -8.48%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 117M USD -8.48%
Liabilities and Equity 123M USD -9.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 5.28M USD -23.7%
Net Cash Provided by (Used in) Financing Activities -3.98M USD -280%
Net Cash Provided by (Used in) Investing Activities 5K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 3.34M shares -8.13%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 940K USD -84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 83M USD -10.7%
Operating Lease, Liability 338K USD -1.17%
Depreciation 156K USD +0.65%
Payments to Acquire Property, Plant, and Equipment 22K USD -48.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12.6M USD -29.9%
Lessee, Operating Lease, Liability, to be Paid 364K USD -4.46%
Property, Plant and Equipment, Gross 33.7M USD -1.7%
Operating Lease, Liability, Current 56K USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 58K USD +41.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 55K USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +33.3%
Deferred Income Tax Expense (Benefit) -192K USD -6300%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26K USD -33.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 55K USD +31%
Current Income Tax Expense (Benefit) 3.27M USD -19.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD +2.33%
Amortization of Intangible Assets 513K USD -67.9%
Share-based Payment Arrangement, Expense 255K USD +13.3%